12th Tumor Models Boston Summit

The 12th Annual Tumor Models Boston Summit is the premier industry-led conference bringing together over 200 experts in preclinical and translational drug discovery to explore the latest advancements in in vivo pharmacology models, advanced 3D in vitro models, and more. Join Reaction Biology as we explore how to optimize and implement more translatable oncology models.

July 23-24, 2024 | Boston, MA

Meet Our Team

Liz Bailey

Liz Bailey

Director of Business Development

Cheryl Davis

Cheryl Davis

General Manager US In vivo

Learn More From Reaction

Donor-dependent anti-tumoral efficacy of human CD19 CAR T cells in a leukemic xenograft mouse model

Donor-dependent anti-tumoral efficacy of human CD19 CAR T cells in a leukemic xenograft mouse model

Comprehensive 27-marker standard panel for immune monitoring of pre-clinical tumor mouse models using spectral analyzer technology

Comprehensive 27-marker standard panel for immune monitoring of pre-clinical tumor mouse models using spectral analyzer technology

In Vivo Models of Bladder Cancer

In Vivo Models of Bladder Cancer

SubQperiorTM The next generation of tumor models

SubQperiorTM The next generation of tumor models

The Hollow Fiber Model: In Vivo Screening Assay to Speed Up Your Drug Discovery Process

The Hollow Fiber Model: In Vivo Screening Assay to Speed Up Your Drug Discovery Process

Premium Drug Discovery Services

Premium Drug Discovery Services

Immuno Oncology Assay Services

Immuno Oncology Assay Services

ADME and Safety: Unlocking the Potential of In Vitro Solutions for Safer Pharmaceuticals

ADME and Safety: Unlocking the Potential of In Vitro Solutions for Safer Pharmaceuticals